載入...
HRI-mediated translational repression reduces proteotoxicity and sensitivity to bortezomib in human pancreatic cancer cells
Human cancer cells display extensive heterogeneity in their sensitivities to the proteasome inhibitor bortezomib (Velcade). The molecular mechanisms underlying this heterogeneity remain unclear, and strategies to overcome resistance are limited. Here, we discover that inherent differences in eIF2α p...
Na minha lista:
| 發表在: | Oncogene |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2018
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6138554/ https://ncbi.nlm.nih.gov/pubmed/29720726 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41388-018-0227-y |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|